Work from delivered nicotine, not from the number on the can. Measured in-mouth extraction after twenty minutes runs roughly 13–23% of a pouch’s nicotine content, and only about 40–60% of what is extracted reaches the blood. A 6 mg pouch at twenty minutes is therefore closer to half a milligram absorbed than to six.
A daily nicotine budget is an arithmetic problem, and almost everyone sets it up wrong. The instinct is to multiply: four 6 mg pouches, 24 mg a day. That number is not wrong so much as meaningless — it is the amount of nicotine that was sitting in the fleece when you opened the can, not the amount that ended up in you. The gap between the two is large, it is variable, and it is the only thing a budget is actually about.
This page is about the method. It is not the page about where the ceiling sits — that question has its own answer in how much nicotine in a day is too much — and it is not about timing, which is nicotine half-life and how to space your pouches. This is how you count.
The number on the can is a content figure, not a dose
Every milligram figure printed on a nicotine pouch tin describes what is in the pouch. Nothing on the tin describes what comes out of it, and the two differ by a factor of four to eight.
Two industry trials with results posted to ClinicalTrials.gov give the cleanest measurement, because they weighed the used pouches afterwards. Imperial Brands’ NCT04891406 measured the “Extraction fraction (%) of nicotine in used product pouches after 20 minutes of use.” Its two tobacco-free pouch arms came out at 13.47% and 14.31%; a third pouch arm reached 18.61%, and the Swedish snus comparator 12.56%. The company’s later study, NCT05452278, reported an outcome it titled “Percentage of Orally Extracted of Nicotine” — the grammatical slip is the registry’s own — and found 19.10%, 22.9% and 21.9% across 14, 16 and 20 mg tobacco-free pouches.
Both are funded by Imperial Brands, which makes the pouches in question. The independent measurement comes from Germany: Mallock-Ohnesorg and colleagues ran 15 smokers through 6, 20 and 30 mg pouches for twenty minutes each, declaring that “The study was funded by intermural funding from the German Federal Institute for Risk Assessment (BfR)” with no commercial relationships. Their “Nicotine extraction (%)” column reads 38%, 24% and 52% for the three strengths — higher than Imperial’s figures, and strikingly non-monotonic.
Those two datasets disagree by a factor of two at the same dwell time, and the standard deviations are enormous — one of Imperial’s arms carries an SD of 10.3 on a mean of 22.9. I would not put much faith in any single “pouches deliver X%” figure, including the ones above. The honest version is a range: somewhere between an eighth and a half of the content comes out in twenty minutes, and which end you land on depends on the product, on you, and on how long you actually keep it in.
Extracted is not absorbed, and that is a second discount
This is the step almost all coverage skips. Nicotine that leaves the pouch has left the pouch. It has not necessarily entered your bloodstream — some is swallowed, and swallowed nicotine is heavily degraded by the liver before it reaches circulation.
The one snus-specific figure comes from Lunell and Lunell’s 2005 crossover study: “The approximate bioavailable dose of nicotine from snus was 40%-60% of the extracted dose.” Read the method before reusing it, because the paper is explicit that this is a comparison, not a mass balance: “Relative bioavailable dose was calculated using AUC of 2-mg Nicorette gum as the reference.” It is a steady-state relative figure against chewing gum, not a recovery experiment. It is also the only number of its kind anyone has published, and the full text is not openly deposited, so the abstract is as far as the public record goes.
Stack the two discounts and the arithmetic changes shape. A 6 mg pouch held for twenty minutes gives up something like 0.8–1.4 mg, of which perhaps 0.3–0.8 mg reaches the blood. Four of them is not 24 mg. It is closer to 1.5–3 mg absorbed across a day.
What the label is worth before you even start
There is a prior problem: the content figure itself is often wrong, and when it is wrong it is usually overstated.
The CDC’s laboratory measured 70 tobacco-free oral nicotine products and concluded that “The measured total nicotine content was either equal to or less than the level stated on the label, except for one product.” A separate analysis from Roswell Park Comprehensive Cancer Center — “This is the first non-industry study to compare nicotine content, release, form, and select flavoring” composition, supported under “Research reported in this publication was supported by the National Cancer Institute (NCI)” awards — found that “For most ONPs, measured nicotine content was consistent with values provided on packages (within 20%;” but that two products were badly out. One Velo line averaged over 60% less nicotine than labelled; a White Fox 12 mg measured about 7.8 mg per pouch, roughly 40% short.
Germany’s federal risk institute found the same direction in its own sampling, and put it bluntly in the paper reporting it: labels of nicotine strength on most products were misleading, with measured contents running from under 2 mg to 47.5 mg per pouch across a 44-product sample. If you are budgeting from a label, build in the possibility that the label is 20% high.
One trap to avoid. The Roswell Park paper also reports how fast pouches release nicotine into water, and those figures approach 100%. They are not delivery figures and the authors say so: “To compare products systematically, we used an experimental approach to facilitate maximal and more rapid nicotine release from products, rather than replicate human oral use.” That is a stirred beaker at 350 rpm. Quoting it as what your mouth does would overstate your intake by a factor of five.
The method, in four steps
Here is how I would actually do it, with each step’s uncertainty kept visible rather than buried.
- Start from measured content where you have it, labelled content where you don’t, and treat the label as an upper bound rather than a fact.
- Apply an extraction fraction based on your real dwell time. Twenty minutes is the common pattern; an hour is what most studies measure. BfR notes that manufacturers themselves recommend shorter sessions, and draws the obvious conclusion — their words are that recommended application times are “of 20 to 30 minutes, from which it can be assumed that less nicotine will be absorbed.”
- Apply the bioavailability discount — 40–60% of what was extracted, on the only published snus figure.
- Multiply by pouch count, and record the count rather than estimating it. The count is the one input you control precisely, and it is the one people misremember most.
Worked through, for a day of four pouches, at the three dwell times the literature actually covers:
| Scenario | Content per pouch | Extraction | Extracted per pouch | Absorbed per pouch (40–60%) | Four pouches absorbed |
|---|---|---|---|---|---|
| 6 mg, 20 min, low end | 6 mg | 13% | 0.8 mg | 0.3–0.5 mg | 1.2–1.9 mg |
| 6 mg, 20 min, high end | 6 mg | 38% | 2.3 mg | 0.9–1.4 mg | 3.6–5.5 mg |
| 9 mg, 30 min | 9 mg | ~25% | 2.3 mg | 0.9–1.4 mg | 3.6–5.4 mg |
| 11 mg, 60 min | 11 mg | ~50% | 5.5 mg | 2.2–3.3 mg | 8.8–13.2 mg |
The middle rows are the realistic ones for most people. The spread between the top and bottom row — roughly sevenfold on the same four pouches — is the whole point. Dwell time and strength do far more work than count does.
One thing the arithmetic cannot tell you
Content does not predict blood level. This is the most counter-intuitive finding in the pouch literature and it holds across independent labs. A six-arm pharmacokinetic study of five pouch brands concluded flatly that “Plasma nicotine concentration was not associated with the nicotine contents of the NPs.” It was funded by the maker of two of them — “The study was supported by British American Tobacco (Investments) Limited, the manufacturer of Lyft and Velo” — but BfR’s own independent work found the same absence of a linear relationship between pouch content and blood nicotine.
So a budget built on milligrams is a budget on input. It is useful for tracking your own trend over weeks and for comparing products you use the same way. It is not a prediction of how any individual pouch will feel, and two pouches of identical strength from different brands routinely do not — which is a question of its own.
Across a day, the doses stack
Budgeting per-pouch misses what repeated dosing does. Nicotine’s elimination half-life is short but not short enough for each pouch to clear before the next one: “The plasma half-life of nicotine after intravenous infusion or cigarette smoking averages about 2 h.” Oral products in particular hold a plateau — “Concentrations of nicotine in the blood rise gradually with the use of smokeless tobacco and plateau at about 30 min,” with levels then declining only slowly.
The consequence, described for smoking but route-independent in its logic: “Peak and trough levels follow each cigarette, but as the day progresses, trough levels rise”. Your fourth pouch of the day lands on a baseline left by the first three. That is why a daily total is a more meaningful number than any single pouch, and why a budget that only counts peaks will understate what a heavy day actually does.
Is there a published daily limit to budget against?
No. There is an acute one, derived for something else entirely, and it is worth understanding precisely because it gets misused.
EFSA established an acute reference dose for nicotine of 0.8 µg/kg body weight in 2009 — derived for nicotine turning up as a contaminant in dried mushrooms, not for a product people buy in order to get nicotine. Germany’s Bavarian state health and food safety authority applied it to pouches anyway in a 2024 risk assessment, declaring “The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.” On their model, a single median-strength pouch exceeds the acute reference dose many times over, and they note that “Consumption of more than one pouch per day would lead to a strikingly higher nicotine dose over the day.”
Three things have to be said about that number if it is quoted. It is an acute value — a single-event reference, not a daily allowance, so comparing a day’s sum against it is not what it was built for. It was derived for a food contaminant. And the conversion runs through an oral bioavailability figure measured on a swallowed capsule, which is not how a pouch is used.
Beyond that, the search comes up empty. No nicotine strength cap for pouches exists in EU law — the Tobacco Products Directive’s only nicotine ceiling is for e-liquid, “(b) the nicotine-containing liquid does not contain nicotine in excess of 20 mg/ml;”, a different product in a different unit. Sweden’s Act 2022:1257 and its implementing ordinance set no numeric nicotine limit at all. The UK’s Tobacco and Vapes Act 2026 takes a delegated power to set one and has not used it. In the United States, authorisation does the limiting indirectly: FDA’s list states that “There are 67 nicotine pouch products authorized by the FDA.” and that “These are the only nicotine pouch products that may be lawfully sold in the United States.”, topping out at a single 11 mg product. The page carries its own caveat: “While these products are authorized to be sold in the United States, it does not mean these products are safe, nor are they “FDA approved.””
So the budget is yours to set. Nobody official has set one for you, and the one number that exists was built for mushrooms.
What people actually use, for calibration
Two different pictures, depending on who is counting. Industry surveys land around five to nine pouches a day; BfR cites one reporting that “On average, respondents consumed 8.6 nicotine pouches per day [7].” — a figure from a study with tobacco-company authors, as BfR’s own note that the underlying pharmacokinetic work was conducted “In this study, financed by a manufacturer” should remind you.
Independent data shows a much longer tail. A Saudi cross-sectional study of 693 current and former smokers found that “A total of 236 NP users (42.1%) reported high-intensity NP use (≥10 pouches/day)”, and a Dutch survey found over 8% of users above twenty a day. If you are calibrating against “average”, be aware that the averages come from the people who sell the product and the tails come from everyone else.
Where a budget actually breaks
In practice I would watch three things more closely than the milligram total.
Dwell time drift. It is the biggest multiplier in the arithmetic and the easiest to stop noticing. Twenty minutes becoming forty doubles the delivered dose at constant count and constant strength.
Strength changes mid-budget. Moving from 6 mg to 9 mg while holding count constant is a 50% increase in input that feels like no change in habit. Whether this is a general pattern is unknown: an NIH- and FDA-funded review of 73 new studies found that “The role of ONPs in the initiation and cessation of cigarettes and other nicotine delivery products remains unclear, lacking population-level longitudinal data on transition patterns.” and contains no instance of the word “escalation” at all. The claim that pouch users inevitably move up is widely made and, as far as I can establish, has never been measured.
Counting by cans. A can is not a reliable unit. Roswell Park’s measurement across seventeen brands found a mean of about 18 pouches per package with a spread of three or four either side — neither the 15 nor the 20 that get quoted as standard.
Frequently asked questions
How many milligrams of nicotine do I actually absorb from a 6 mg pouch?
On the published extraction and bioavailability figures, roughly 0.3–1.4 mg at twenty minutes, depending on product and on you. The wide range is real and nobody has narrowed it.
Does holding a pouch longer give more nicotine?
Yes, substantially — extraction roughly doubles or triples between twenty and sixty minutes. BfR notes the practical implication: manufacturers recommend shorter sessions than the studies measure, so less is absorbed in ordinary use than the 60-minute literature implies.
Is there a safe daily number of pouches?
No authority publishes one, and this site will not invent one. Nicotine is addictive and no nicotine product is safe. What a budget gives you is a consistent measurement of your own trend, not a safety threshold.
Can I compare my pouch total to a cigarette total?
Only loosely, and not by milligrams on the package. The delivery curves differ, the absorbed fractions differ, and content does not predict blood level in either product. Treat any equivalence figure as an order-of-magnitude comparison at best.
Why do two pouches of the same strength feel different?
Because pH, moisture, pouch mass and fleece all change how fast nicotine leaves the pouch. Roswell Park found that “Nearly all ONP manufacturers acknowledged using chemicals to modify pouch pH, most commonly sodium bicarbonate and sodium carbonate”, and pH drives the free-base fraction that crosses the mucosa.
Should I budget by milligrams or by count?
Count is what you can measure reliably; milligrams are what you are actually trying to control. Record the count and the dwell time, and convert — the conversion is where the information is.
If you are working the other direction — trying to bring a total down rather than measure it — stepping down your strength and strength creep cover the ground this page deliberately leaves alone. For the same arithmetic on the tobacco side, see how much nicotine is absorbed from a snus portion, and for what the strengths themselves mean, the pillar is nicotine pouch strengths: the complete mg guide. Related questions on this site: can you use two nicotine pouches at once?, how many pouches are in a can, measured vs labelled nicotine and signs of too much nicotine. If you want a ranked starting point rather than a calculation, there is the master ranking.
Sources
- ClinicalTrials.gov, NCT04891406 — Imperial Brands PLC, n=24, results posted 13 October 2023. Extraction fractions at 20 minutes: 13.47% (SD 5.321), 14.31% (SD 8.181), 18.61% (SD 8.608) for pouch arms; 12.56% (SD 5.010) for Skruf snus.
- ClinicalTrials.gov, NCT05452278 — Imperial Brands PLC, n=27. Tobacco-free pouch extraction at 20 minutes: 19.10% (SD 9.98), 22.9% (SD 10.3), 21.9% (SD 9.77).
- Mallock-Ohnesorg N et al., Nicotine pouches: a summary of in vivo data, Frontiers in Pharmacology, 2024. BfR intramural funding, no commercial relationships declared. 15 subjects, 20-minute use, extraction 38% / 24% / 52% for 6, 20 and 30 mg pouches.
- Lunell E, Lunell M, Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum, Nicotine & Tobacco Research, 2005 (PMID 16085507). Abstract only; no open full text is deposited.
- German Federal Institute for Risk Assessment, Health risk assessment of nicotine pouches, Updated BfR Opinion no. 023/2022, 7 October 2022.
- Page MK, Leigh NJ, Goniewicz ML et al., Comparison of Nicotine and Selected Flavoring Contents Between Tobacco-Free and Tobacco-Containing Oral Pouches, Nicotine & Tobacco Research. NCI-funded (U54 CA228110, P01 CA200512).
- Tran H, Tyx RE, Stanfill SB, Watson CH et al., Total and unprotonated (freebase) nicotine content in new types of oral ‘tobacco-free’ nicotine products, Tobacco Control. CDC Division of Laboratory Sciences.
- Mallock N et al., Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches, Tobacco Control 2024;33(2):193–199. BfR Department of Chemical and Product Safety.
- Benowitz NL, Hukkanen J, Jacob P, Nicotine Chemistry, Metabolism, Kinetics and Biomarkers, Handbook of Experimental Pharmacology 2009;(192):29–60. NIDA grants DA02277 and DA12393.
- Azzopardi D et al., A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette, European Journal of Drug Metabolism and Pharmacokinetics, 2022. Funded by British American Tobacco.
- Reimann H et al., Beyond smoking: Risk assessment of nicotine in pouches, Toxicology Reports, 2024. Bavarian Health and Food Safety Authority; no competing interests declared.
- US Food and Drug Administration, Nicotine Pouch Products Authorized by the FDA. Page content current as of 30 October 2026.
- Directive 2014/40/EU of the European Parliament and of the Council, consolidated PDF, Article 20(3)(b).
- Lag (2022:1257) om tobaksfria nikotinprodukter and Förordning (2022:1263); Tobacco and Vapes Act 2026.
- Nguyen-Grozavu F et al., Oral nicotine pouches and public health: evidence from an updated scoping review, Nicotine & Tobacco Research. NIH/NCI and FDA grant 2U54CA229974.
- Cross-sectional study of nicotine pouch use intensity among current and former smokers, Frontiers in Public Health, 2026. King Abdulaziz University endowment funding.
Last verified 9 November 2026. Extraction and bioavailability figures are from the studies named above; where a figure comes from a manufacturer-funded study, the funding is stated in the text.
